73 related articles for article (PubMed ID: 22863925)
1. Benzofuran derivatives inhibit 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose tissue.
Kiyonaga D; Tagawa N; Yamaguchi Y; Wakabayashi M; Kogure T; Ueda M; Miyata O; Kobayashi Y
Biol Pharm Bull; 2012; 35(8):1275-80. PubMed ID: 22863925
[TBL] [Abstract][Full Text] [Related]
2. Visceral fat sympathectomy ameliorates systemic and local stress response related to chronic sleep restriction.
Azuara-Alvarez LE; Díaz-Muñoz M; Báez Ruiz A; Saderi N; Ramírez-Plascencia OD; Cárdenas-Romero S; Flores-Sandoval O; Salgado-Delgado R
Exp Biol Med (Maywood); 2023 Dec; 248(23):2381-2392. PubMed ID: 38143435
[TBL] [Abstract][Full Text] [Related]
3. Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice.
Wamil M; Battle JH; Turban S; Kipari T; Seguret D; de Sousa Peixoto R; Nelson YB; Nowakowska D; Ferenbach D; Ramage L; Chapman KE; Hughes J; Dunbar DR; Seckl JR; Morton NM
Diabetes; 2011 Apr; 60(4):1158-67. PubMed ID: 21350084
[TBL] [Abstract][Full Text] [Related]
4. Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1.
Su X; Pradaux-Caggiano F; Vicker N; Thomas MP; Halem H; Culler MD; Potter BV
ChemMedChem; 2011 Sep; 6(9):1616-29. PubMed ID: 21714097
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.
Paterson JM; Morton NM; Fievet C; Kenyon CJ; Holmes MC; Staels B; Seckl JR; Mullins JJ
Proc Natl Acad Sci U S A; 2004 May; 101(18):7088-93. PubMed ID: 15118095
[TBL] [Abstract][Full Text] [Related]
6. Memory deficits in a juvenile rat model of type 1 diabetes are due to excess 11β-HSD1 activity, which is upregulated by high glucose concentrations rather than insulin deficiency.
Brossaud J; Bosch-Bouju C; Marissal-Arvy N; Campas-Lebecque MN; Helbling JC; Webster SP; Walker BR; Fioramonti X; Ferreira G; Barat P; Corcuff JB; Moisan MP
Diabetologia; 2023 Sep; 66(9):1735-1747. PubMed ID: 37300580
[TBL] [Abstract][Full Text] [Related]
7. Halogenated bisphenol A derivatives potently inhibit human and rat 11β-hydroxysteroid dehydrogenase 1: Structure-activity relationship and molecular docking.
Wang H; Sang J; Ji Z; Yu Y; Wang S; Zhu Y; Li H; Wang Y; Ge RS
Environ Toxicol; 2024 May; 39(5):2560-2571. PubMed ID: 38189224
[TBL] [Abstract][Full Text] [Related]
8. Vertical sleeve gastrectomy normalizes circulating glucocorticoid levels and lowers glucocorticoid action tissue-selectively in mice.
Akalestou E; Lopez-Noriega L; Christakis I; Hu M; Miras AD; Leclerc I; Rutter GA
Front Endocrinol (Lausanne); 2022; 13():1020576. PubMed ID: 36246869
[TBL] [Abstract][Full Text] [Related]
9. UV-filter benzophenones suppress human, pig, rat, and mouse 11β-hydroxysteroid dehydrogenase 1: Structure-activity relationship and in silico docking analysis.
Hao T; Zhao X; Ji Z; Xia M; Lu H; Sang J; Wang S; Li L; Ge RS; Zhu Q
Comp Biochem Physiol C Toxicol Pharmacol; 2024 Jul; 281():109900. PubMed ID: 38518984
[TBL] [Abstract][Full Text] [Related]
10. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.
Fenton CG; Doig CL; Fareed S; Naylor A; Morrell AP; Addison O; Wehmeyer C; Buckley CD; Cooper MS; Lavery GG; Raza K; Hardy RS
Arthritis Res Ther; 2019 Aug; 21(1):188. PubMed ID: 31420008
[TBL] [Abstract][Full Text] [Related]
11. In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 1 activity.
Kley M; Moser SO; Winter DV; Odermatt A
Methods Enzymol; 2023; 689():121-165. PubMed ID: 37802569
[TBL] [Abstract][Full Text] [Related]
12. Distinct inhibitory strength of bisphenol A analogues on human and rat 11β-hydroxysteroid dehydrogenase 1: 3D quantitative structure-activity relationship and in silico molecular docking analysis.
Lu H; Wang S; Zheng J; Zhu Y; Wang Y; Li H; Ge RS
Ecotoxicol Environ Saf; 2023 Nov; 267():115638. PubMed ID: 37918333
[TBL] [Abstract][Full Text] [Related]
13. JTT-654, an 11-beta hydroxysteroid dehydrogenase type 1 inhibitor, improves hypertension and diabetic kidney injury by suppressing angiotensinogen production.
Heitaku S; Sasase T; Sotani T; Maki M; Kawai T; Morinaga H; Nishiu J
J Pharmacol Sci; 2024 Apr; 154(4):246-255. PubMed ID: 38485342
[TBL] [Abstract][Full Text] [Related]
14. Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension.
Westgate CSJ; Markey K; Mitchell JL; Yiangou A; Singhal R; Stewart P; Tomlinson JW; Lavery GG; Mollan SP; Sinclair AJ
Eur J Endocrinol; 2022 Aug; 187(2):323-333. PubMed ID: 35584002
[TBL] [Abstract][Full Text] [Related]
15. β-Adrenergic Stimulation-Induced PVAT Dysfunction in Male Sex: A Role for 11β-Hydroxysteroid Dehydrogenase-1.
Victorio JA; Barssotti L; Aprahamian T; Costa RG; Mousovich-Neto F; Oliveira HCF; Mori M; Rossoni LV; Davel AP
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38712392
[TBL] [Abstract][Full Text] [Related]
16. 11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis.
Davidson CT; Miller E; Muir M; Dawson JC; Lee M; Aitken S; Serrels A; Webster SP; Homer NZM; Andrew R; Brunton VG; Hadoke PWF; Walker BR
PLoS One; 2023; 18(3):e0255709. PubMed ID: 36940215
[TBL] [Abstract][Full Text] [Related]
17. Chalcones from plants cause toxicity by inhibiting human and rat 11β-hydroxysteroid dehydrogenase 2: 3D-quantitative structure-activity relationship (3D-QSAR) and in silico docking analysis.
Lin H; Su M; Wen C; Tang Y; Li H; Wu Y; Ge RS; Li XW; Lin H
Food Chem Toxicol; 2024 Feb; 184():114415. PubMed ID: 38141941
[TBL] [Abstract][Full Text] [Related]
18. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.
Masuzaki H; Yamamoto H; Kenyon CJ; Elmquist JK; Morton NM; Paterson JM; Shinyama H; Sharp MG; Fleming S; Mullins JJ; Seckl JR; Flier JS
J Clin Invest; 2003 Jul; 112(1):83-90. PubMed ID: 12840062
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of 11β-hydroxysteroid dehydrogenase 1 in visceral adipose tissue and underexpression of endothelial nitric oxide synthase in the adrenal cortex of dogs with hyperadrenocorticism.
Miceli DD; Abiuso AMB; Vidal PN; Gallelli MF; Pignataro OP; Castillo VA
Open Vet J; 2018; 8(1):77-85. PubMed ID: 29721436
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Hsd11b1 suppresses caloric-restriction-induced bone marrow adiposity in male but not female mice.
Lovdel A; Suchacki K; Roberts F; Sulston RJ; Wallace RJ; Thomas BJ; Bell RMB; Pruñonosa Cervera I; Macpherson G; Morton N; Homer NZZM; Chapman KE; Cawthorn WP
J Endocrinol; 2024 May; ():. PubMed ID: 38805506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
